All In Biotech

Free tool

FAERS Monitor: Rasuvo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 205776 or its brand name (Rasuvo, Methotrexate). Reports on generic versions are filed under their own applications.

Reports

419,222

Serious

315,734

75% of reports

Hospitalization

119,931

Death reported

34,424

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective76,167
  • rheumatoid arthritis38,742
  • arthralgia37,040
  • pain36,175
  • off label use35,398
  • fatigue29,748
  • nausea24,560
  • joint swelling22,754
  • headache21,380
  • rash20,425
  • condition aggravated20,328
  • drug intolerance20,034
  • diarrhoea18,733
  • pain in extremity18,205
  • pyrexia17,500

Reports by year received

View as table
YearReports
20045,129
20055,083
20064,969
20077,782
20088,995
20099,160
20109,678
201110,610
201214,953
201316,975
201416,960
201520,367
201621,911
201722,794
201832,709
201932,625
202039,943
202126,674
202229,451
202327,028
202423,322
202520,237
202611,858

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,634,937 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
rheumatoid arthritisSignal38,74225.525.2603,262
drug intoleranceSignal20,03412.912.7174,560
joint swellingSignal22,75411.411.3176,592
arthralgiaSignal37,0404.84.8103,833
condition aggravatedSignal20,3283.53.534,777
pain in extremitySignal18,2053.23.226,795
painSignal36,1753.13.049,161
drug ineffectiveSignal76,1673.03.0103,174
pyrexiaSignal17,5002.62.616,910
rashSignal20,4252.42.416,518
off label useSignal35,3982.12.119,643
fatigue29,7482.01.913,825
headache21,3801.71.76,641
nausea24,5601.61.65,186
diarrhoea18,7331.51.42,816

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.